Migraine with Aura: Treatment Recommendations
For acute treatment of migraine with aura, start NSAIDs (aspirin, ibuprofen, naproxen, or diclofenac) immediately during the aura phase, then escalate to triptans when headache begins if NSAIDs fail; for prevention, use propranolol, timolol, amitriptyline, or divalproex sodium as first-line agents.
Acute Treatment Algorithm
First-Line: NSAIDs During Aura
Start NSAIDs or aspirin as soon as the aura begins—not to treat the aura itself, but to prevent or diminish the subsequent headache phase 1, 2. The strongest evidence supports:
- Aspirin
- Ibuprofen
- Naproxen sodium
- Diclofenac potassium
Critical timing point: Do NOT wait for headache to start. Begin treatment during visual or sensory aura symptoms 3.
Second-Line: Triptans When Headache Begins
If NSAIDs fail or provide inadequate relief, use triptans when the headache phase starts, not during aura 1, 4. Evidence-based options include:
- Oral: naratriptan, rizatriptan, zolmitriptan, sumatriptan
- Subcutaneous sumatriptan for rapid-onset or severe attacks
- DHE nasal spray as alternative
Important caveat: Triptans should NOT be taken during the aura phase itself—wait until headache begins 2.
Combination Therapy
For patients requiring escalation, combine a triptan with an NSAID rather than using triptan monotherapy 4. This combination provides superior efficacy and is cost-effective (approximately $500 annually vs. $5,994-$6,668 for newer CGRP antagonists).
Third-Line Options
Consider CGRP antagonists (rimegepant, ubrogepant, zavegepant) or dihydroergotamine only when combination therapy of triptan plus NSAID fails 4. These are substantially more expensive without clear superiority in outcomes.
Route of Administration
Use non-oral routes (nasal spray, subcutaneous injection) when nausea/vomiting occurs early in the attack 1. Add antiemetics—nausea itself is disabling and warrants treatment even without vomiting 1.
Preventive Treatment Algorithm
Indications for Prevention
Initiate preventive therapy when patients have 1:
- ≥2 attacks/month causing disability lasting ≥3 days/month
- Contraindication to or failure of acute treatments
- Acute medication use >2 times/week
- Uncommon migraine conditions including hemiplegic migraine, migraine with prolonged aura, or migrainous infarction
Note: Migraine with prolonged aura specifically warrants preventive therapy even if frequency is lower 1.
First-Line Preventive Agents
The following have proven efficacy with specific dosing 1:
- Propranolol: 80-240 mg/day
- Timolol: 20-30 mg/day
- Amitriptyline: 30-150 mg/day
- Divalproex sodium: 500-1,500 mg/day
- Sodium valproate: 800-1,500 mg/day
Start low and titrate slowly—clinical benefit may take 2-3 months to manifest 1. Each agent deserves an adequate trial before declaring failure.
Alternative Agents for Migraine with Aura
For patients specifically with frequent or prolonged auras, consider 5:
- Lamotrigine: Inhibits glutamate release (implicated in aura pathophysiology)
- Flunarizine: 10 mg/day (where available)
These target the underlying cortical spreading depression mechanism of aura 2, 6.
Second-Line Preventive Options
If first-line agents fail, consider 7:
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab)
- CGRP antagonist-gepants (atogepant, rimegepant)
- Topiramate (if β-blockers, valproate, venlafaxine, and amitriptyline all fail)
Cost consideration: CGRP-mAbs and gepants cost substantially more (thousands annually) without clear superiority over traditional agents 7. Reserve for treatment-refractory cases.
Special Considerations for Migraine with Aura
Stroke Risk
Migraine with aura carries modestly increased ischemic stroke risk 2, 6. This has critical implications:
- Absolutely avoid combined hormonal contraception with estrogens in women with migraine with aura 2
- Consider antiplatelet therapy (aspirin, picotamide) for dual benefit: migraine prevention and stroke risk reduction 5
Distinguishing Aura from TIA
Aura symptoms develop gradually over ≥5 minutes and occur in succession (typically visual→sensory→aphasic), whereas TIA symptoms have sudden, simultaneous onset 3, 2.
Red flags requiring emergency evaluation 2:
- First-time aura with no gradual onset
- Neurological symptoms corresponding to vascular territory
- Aura without visual symptoms
- Simultaneous (not successive) neurological symptoms
- Aura duration >1 hour
- Late-onset aura (new onset in older adults)
- Dramatic increase in aura frequency
Treatment Titration Strategy
- Start with low-dose preventive medication
- Titrate slowly until clinical benefit achieved or adverse events limit dosing
- Continue for 2-3 months minimum before assessing efficacy
- Avoid overuse of acute medications (especially ergotamine) during preventive therapy 1
- After stability achieved, consider tapering or discontinuing
- Use headache diaries to track frequency, severity, duration, and medication response 1
Medication Overuse Headache Prevention
Educate patients that using acute medications >2 days/week risks medication overuse headache 3. This is particularly important in migraine with aura where anxiety about aura symptoms may drive excessive acute medication use.